Skip to content
News
We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.
November 22, 2023
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement
READ MORE
September 26, 2023
Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device
READ MORE
August 18, 2023
Satio Partners with BARDA DRIVe to Develop a Novel Patch-based Ebolavirus Diagnostic
READ MORE
July 17, 2023
Sapphiros Appoints Industry Veteran Andrew Garfield to Lead Technology Transfer to Manufacturing
READ MORE
June 6, 2023
GrapheneDx, General Graphene Corp and Sapphiros Enter Into Strategic Partnership to Industrialize Graphene-Based Biosensors to Revolutionize Point of Care and Consumer Diagnostics
READ MORE
April 17, 2023
Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test
READ MORE
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us